These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20852289)

  • 1. Inpatient vs. elective outpatient cardiac resynchronization therapy device implantation and long-term clinical outcome.
    Ajijola OA; Macklin EA; Moore SA; McCarty D; Bischoff KE; Heist EK; Picard M; Ruskin JN; Dec GW; Singh JP
    Europace; 2010 Dec; 12(12):1745-9. PubMed ID: 20852289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response and outcomes of cardiac resynchronization therapy in patients with renal dysfunction.
    Moreira RI; Cunha PS; Rio P; da Silva MN; Branco LM; Galrinho A; Feliciano J; Soares R; Ferreira RC; Oliveira MM
    J Interv Card Electrophysiol; 2018 Apr; 51(3):237-244. PubMed ID: 29460235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inpatients are sicker than outpatients; finally it's evidence-based.
    Dickstein K
    Europace; 2010 Dec; 12(12):1662-3. PubMed ID: 21045014
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT.
    Skali H; Dwyer EM; Goldstein R; Haigney M; Krone R; Kukin M; Lichstein E; McNitt S; Moss AJ; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2014 May; 16(5):560-5. PubMed ID: 24578164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular lead implantation at a phrenic stimulation site is safe and effective.
    Jastrzebski M; Bacior B; Wojciechowska W; Czarnecka D
    Europace; 2011 Apr; 13(4):520-5. PubMed ID: 21242156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac resynchronization therapy for mild heart failure: the time has come.
    Reynolds CR; Gold MR
    Circulation; 2011 Jan; 123(2):195-202. PubMed ID: 21242505
    [No Abstract]   [Full Text] [Related]  

  • 7. The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume.
    Bogale N; Priori S; Gitt A; Alings M; Linde C; Dickstein K;
    Europace; 2011 Oct; 13(10):1445-53. PubMed ID: 21712274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary note.
    Tang WH; Francis GS
    Circulation; 2011 Jan; 123(2):203-8. PubMed ID: 21242506
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary sinus atresia complicating cardiac resynchronization therapy.
    Nakamura T; Otomo K; Kawai S; Igawa O
    J Cardiovasc Electrophysiol; 2010 Oct; 21(10):1178. PubMed ID: 20522151
    [No Abstract]   [Full Text] [Related]  

  • 10. Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes.
    Goldstein SA; Mentz RJ; Hellkamp AS; Randolph TC; Fonarow GC; Hernandez A; Yancy CW; Al-Khatib SM
    Clin Cardiol; 2019 Feb; 42(2):256-263. PubMed ID: 30548280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and clinical implications of cardiac resynchronization therapy on outcomes of diabetic patients with heart failure.
    Santangelo G; Dugo D; Mulè M; Puzzangara E; Schillaci V; Timineri S; Capranzano P; Di Grazia A; Liotta C; Scandura S; Ragusa A; Tamburino C; Calvi V
    J Cardiovasc Med (Hagerstown); 2011 Jun; 12(6):396-400. PubMed ID: 21139508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ Upgrading of cardiac resynchronization therapy devices in patients with heart failure--uprising clinical problem. ].
    Przybylski A
    Kardiol Pol; 2010 Nov; 68(11):1242. PubMed ID: 21108201
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and prognostic role of pressure-volume relationship in the identification of responders to cardiac resynchronization therapy.
    Ciampi Q; Pratali L; Citro R; Villari B; Picano E; Sicari R
    Am Heart J; 2010 Nov; 160(5):906-14. PubMed ID: 21095279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a tool combining guide-wire and stylet for the left ventricular lead positioning.
    Giannola G; Iacopino S; Lombardo E; Cesario A; Di Stefano G; Piraino LG; Campisi G; Torcivia R; Corrao D; Risi A; Denaro A; Valsecchi S;
    Europace; 2011 Feb; 13(2):244-50. PubMed ID: 21131651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study.
    Gasparini M; Steinberg JS; Arshad A; Regoli F; Galimberti P; Rosier A; Daubert JC; Klersy C; Kamath G; Leclercq C
    Eur Heart J; 2010 Apr; 31(8):976-83. PubMed ID: 20071325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of right ventricular peak systolic pressure to major adverse events in patients undergoing cardiac resynchronization therapy.
    Tedrow UB; Kramer DB; Stevenson LW; Stevenson WG; Baughman KL; Epstein LM; Lewis EF
    Am J Cardiol; 2006 Jun; 97(12):1737-40. PubMed ID: 16765124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial.
    Arshad A; Moss AJ; Foster E; Padeletti L; Barsheshet A; Goldenberg I; Greenberg H; Hall WJ; McNitt S; Zareba W; Solomon S; Steinberg JS;
    J Am Coll Cardiol; 2011 Feb; 57(7):813-20. PubMed ID: 21310317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function and mortality following cardiac resynchronization therapy.
    Lin G; Gersh BJ; Greene EL; Redfield MM; Hayes DL; Brady PA
    Eur Heart J; 2011 Jan; 32(2):184-90. PubMed ID: 21068051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.